0001371285-17-000082.txt : 20170503
0001371285-17-000082.hdr.sgml : 20170503
20170503174207
ACCESSION NUMBER: 0001371285-17-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170503
DATE AS OF CHANGE: 20170503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRUPANION INC.
CENTRAL INDEX KEY: 0001371285
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98108
BUSINESS PHONE: 888-733-2685
MAIL ADDRESS:
STREET 1: 6100 4TH AVENUE SOUTH
STREET 2: SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98108
FORMER COMPANY:
FORMER CONFORMED NAME: VETINSURANCE INTERNATIONAL INC
DATE OF NAME CHANGE: 20060802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAWLINGS DARRYL
CENTRAL INDEX KEY: 0001611679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36537
FILM NUMBER: 17810776
MAIL ADDRESS:
STREET 1: 907 NW BALLARD WAY
CITY: SEATTLE
STATE: WA
ZIP: 98107
4
1
wf-form4_149384771242258.xml
FORM 4
X0306
4
2017-05-01
0
0001371285
TRUPANION INC.
TRUP
0001611679
RAWLINGS DARRYL
C/O TRUPANION, INC.
6100 4TH AVENUE SOUTH, SUITE 200
SEATTLE
WA
98108
1
1
0
0
President and CEO
Common Stock
2017-05-01
4
S
0
3500
16.21
D
1477505
D
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 31, 2016, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025.
These shares were sold at a single execution price of $16.21 per share.
/s/ Charlotte Sim-Warner as attorney-in-fact for Darryl Rawlings
2017-05-03